VITA — Vitaminka AD Prilep Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedMicro CapTurnaround

Annual income statement for Vitaminka AD Prilep, fiscal year end - December 31st, MKD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	—	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,351	2,824	3,812	3,247	3,501
Cost of Revenue
Gross Profit	805	795	865	1,081	1,173
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,285	2,704	3,700	3,069	3,328
Operating Profit	66.5	120	112	178	173
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	29.3	83.2	75.3	109	100
Provision for Income Taxes
Net Income After Taxes	25.8	76.2	69.8	99.3	90
Net Income Before Extraordinary Items
Net Income	25.8	76.2	69.8	99.3	90
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	25.8	76.2	69.8	99.3	90
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	362	953	939	1,267	1,108
Dividends per Share